1. ScholarBank@NUS
  2. Research Outputs

Browsing by Author WANG LINGZHI

Select a letter below to browse by last name or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


Showing results 1 to 20 of 38  next >
Issue DateTitleAuthor(s)
Apr-2008A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cellsMa, B.; Goh, B.C.; Tan, E.H.; Lam, K.C.; Soo, R. ; Leong, S.S.; Wang, L.Z. ; Mo, F.; Chan, A.T.C.; Zee, B.; Mok, T.
Jul-2006A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancerSoo, R.A. ; Wang, L.Z. ; Tham, L.S.; Yong, W.P. ; Boyer, M.; Lim, H.L.; Lee, H.S.; Millward, M.; Liang, S.; Beale, P.; Lee, S.C. ; Goh, B.C.
Jul-2008A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancersYong, W.-P. ; Wang, L.-Z. ; Tham, L.-S.; Wong, C.-I.; Lee, S.-C. ; Soo, R. ; Sukri, N.; Lee, H.-S.; Goh, B.-C.
2003A rapid and sensitive liquid chromatography/tandem mass spectrometry method for determination of docetaxel in human plasmaWang, L.Z. ; Goh, B.C.; Grigg, M.E.; Lee, S.C.; Khoo, Y.M.; Lee, H.S.
Sep-2010A sensitive and specific liquid chromatography-tandem mass spectrometric method for determination of belinostat in plasma from liver cancer patientsWang, L.-Z. ; Chan, D.; Yeo, W.; Wan, S.-C.; Chan, S.; Chan, A.; Lee, S.-C.; Lee, H.-S.; Goh, B.-C.
Oct-2006A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9Tham, L.-S.; Goh, B.-C.; Nafziger, A.; Guo, J.-Y. ; Wang, L.-Z. ; Soong, R. ; Lee, S.-C. 
Oct-2003An expedient assay for determination of gemcitabine and its metabolite in human plasma using isocratic ion-pair reversed-phase high-performance liquid chromatographyWang, L.-Z. ; Goh, B.-C.; Lee, H.-S.; Noordhuis, P.; Peters, G.J.
4-Dec-2012Combination Therapy with Gossypol Reveals Synergism against Gemcitabine Resistance in Cancer Cells with High BCL-2 ExpressionWong, F.Y.; Liem, N.; Xie, C.; Yan, F.L.; Wong, W.C.; Wang, L. ; Yong, W.-P. 
Dec-2008Does saturable formation of gemcitabine triphosphate occur in patients?Tham, L.-S.; Wang, L.-Z. ; Soo, R.A. ; Lee, H.-S.; Lee, S.-C. ; Goh, B.-C.; Holford, N.H.G.
28-Feb-2008Drying efficiency and particle movement in coating-Impact on particle agglomeration and yieldTang, E.S.K.; Wang, L. ; Liew, C.V. ; Chan, L.W. ; Heng, P.W.S. 
2001Effect of cetrimide and ascorbic acid on in vitro human skin permeation of haloperidolVaddi, H.K.; Wang, L.Z. ; Ho, P.C.-L. ; Chan, Y.W.; Chan, S.Y. 
16-Jan-2001Effect of some enhancers on the permeation of haloperidol through rat skin in vitroVaddi, H.K.; Wang, L.Z. ; Ho, P.C. ; Chan, S.Y. 
20-Nov-2006Effects of high dose of simvastatin on levels of dopamine and its reuptake in prefrontal cortex and striatum among SD ratsWang, Q.; Tang, X.N.; Wang, L. ; Yenari, M.A.; Ying, W.; Goh, B.-C.; Lee, H.-S.; Wilder-Smith, E.P.; Wong, P.T.
20-Sep-2012Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase II consortium and the cancer therapeutics research groupYeo, W.; Chung, H.C.; Chan, S.L.; Wang, L.Z. ; Lim, R.; Picus, J.; Boyer, M.; Mo, F.K.F.; Koh, J.; Rha, S.Y.; Hui, E.P.; Jeung, H.C.; Roh, J.K.; Yu, S.C.H.; To, K.F.; Tao, Q.; Ma, B.B.; Chan, A.W.H.; Tong, J.H.M.; Erlichman, C.; Chan, A.T.C.; Goh, B.C.
1-Sep-2002Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategiesGoh, B.-C.; Lee, S.-C. ; Wang, L.-Z. ; Fan, L.; Guo, J.-Y. ; Lamba, J.; Schuetz, E.; Lim, R.; Lim, H.-L.; Ong, A.-B.; Lee, H.-S.
17-Jun-2019FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling PathwayWang Lingzhi 
Jul-2013Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancerTan, T.Z.; Miow, Q.H.; Huang, R.Y.-J.; Wong, M.K.; Ye, J.; Lau, J.A.; Wu, M.C. ; Bin Abdul Hadi, L.H.; Soong, R. ; Choolani, M.; Davidson, B.; Nesland, J.M.; Wang, L.-Z. ; Matsumura, N.; Mandai, M.; Konishi, I.; Goh, B.-C.; Chang, J.T.; Thiery, J.P. ; Mori, S. 
30-Jan-2013Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer PatientsWang, L.-Z. ; Ramírez, J.; Yeo, W.; Chan, M.-Y.M.; Thuya, W.-L. ; Lau, J.-Y.A.; Wan, S.-C.; Wong, A.L.-A.; Zee, Y.-K.; Lim, R.; Lee, S.-C. ; Ho, P.C. ; Lee, H.-S.; Chan, A.; Ansher, S.; Ratain, M.J.; Goh, B.-C.
3-Aug-2012Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKLWen, Q.; Goldenson, B.; Silver, S.J.; Schenone, M.; Dancik, V.; Huang, Z.; Wang, L.-Z. ; Lewis, T.A.; An, W.F.; Li, X.; Bray, M.-A.; Thiollier, C.; Diebold, L.; Gilles, L.; Vokes, M.S.; Moore, C.B.; Bliss-Moreau, M.; Verplank, L.; Tolliday, N.J.; Mishra, R.; Vemula, S.; Shi, J.; Wei, L.; Kapur, R.; Lopez, C.K.; Gerby, B.; Ballerini, P.; Pflumio, F.; Gilliland, D.G.; Goldberg, L.; Birger, Y.; Izraeli, S.; Gamis, A.S.; Smith, F.O.; Woods, W.G.; Taub, J.; Scherer, C.A.; Bradner, J.E.; Goh, B.-C.; Mercher, T.; Carpenter, A.E.; Gould, R.J.; Clemons, P.A.; Carr, S.A.; Root, D.E.; Schreiber, S.L.; Stern, A.M.; Crispino, J.D.
Apr-2006Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drugTham, L.-S.; Lee, H.-S.; Wang, L. ; Yong, W.-P. ; Fan, L.; Ong, A.-B.; Sukri, N.; Soo, R. ; Lee, S.-C. ; Goh, B.-C.
Showing results 1 to 20 of 38  next >